Keep Different Weight Loss Meds Straight During Transitions of Care

Please see the February 2020 FDA recommendation to remove Belviq and Belviq XR from the market.

New versions of phentermine (Lomaira, loh-MER-uh) and lorcaserin (Belviq XR) will add to the plethora of weight loss meds.

Over one in three Americans are obese...and many are turning to medications to help lose weight.

Develop transitions-of-care plans for these meds.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote